The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Watson, Allan Mark
    Director born in January 1967
    Individual (5 offsprings)
    Officer
    2021-12-21 ~ now
    OF - Director → CIF 0
  • 2
    Mclean, Andrew Firth
    Director born in August 1965
    Individual (7 offsprings)
    Officer
    2021-12-21 ~ now
    OF - Director → CIF 0
  • 3
    Inker, Mark Charles
    Uk General Manager born in June 1964
    Individual (3 offsprings)
    Officer
    2023-02-20 ~ now
    OF - Director → CIF 0
  • 4
    Stratford, Harry Thomas, Dr
    Company Director born in November 1970
    Individual (11 offsprings)
    Officer
    2021-12-21 ~ now
    OF - Director → CIF 0
  • 5
    17, Godliman Street, London, England
    Active Corporate (5 parents, 2 offsprings)
    Person with significant control
    2021-12-21 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 9
  • 1
    Scullion, Stephen Peter
    Director born in November 1967
    Individual (1 offspring)
    Officer
    2015-02-01 ~ 2016-10-14
    OF - Director → CIF 0
  • 2
    Westaway, Karen Mary
    Director born in January 1958
    Individual (3 offsprings)
    Officer
    2013-10-09 ~ 2015-04-01
    OF - Director → CIF 0
  • 3
    Thorburn, Alastair
    Director born in March 1955
    Individual
    Officer
    2013-10-09 ~ 2014-12-31
    OF - Director → CIF 0
  • 4
    Cook, Mark
    Director born in February 1966
    Individual (2 offsprings)
    Officer
    2013-10-09 ~ 2021-12-21
    OF - Director → CIF 0
  • 5
    Alsop, Matthew Robert
    Financial Consultant born in May 1971
    Individual (4 offsprings)
    Officer
    2013-10-09 ~ 2016-10-13
    OF - Director → CIF 0
  • 6
    Perrie, Sean Ambrose
    Pharmaceutical Marketing Executive born in April 1992
    Individual (2 offsprings)
    Officer
    2013-06-26 ~ 2021-12-21
    OF - Director → CIF 0
    Mr Sean Ambrose Perrie
    Born in April 1992
    Individual (2 offsprings)
    Person with significant control
    2016-04-06 ~ 2021-12-21
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 7
    Farquharson, Carol Ann
    Sales Director born in September 1961
    Individual (4 offsprings)
    Officer
    2014-01-31 ~ 2017-01-04
    OF - Director → CIF 0
  • 8
    Mcmenemy, Philip, Dr
    Director born in December 1958
    Individual (1 offspring)
    Officer
    2013-10-09 ~ 2016-09-05
    OF - Director → CIF 0
  • 9
    Neumaier, Gerhard Wilhelm
    Director born in February 1957
    Individual
    Officer
    2014-07-15 ~ 2017-07-14
    OF - Director → CIF 0
parent relation
Company in focus

STIRLING ANGLIAN PHARMACEUTICALS LIMITED

Previous name
STIRLING ANGLIAN LIMITED - 2013-07-12
Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Intangible Assets
14,502 GBP2021-12-31
87,290 GBP2020-12-31
Property, Plant & Equipment
2,297 GBP2021-12-31
2,287 GBP2020-12-31
Fixed Assets
16,799 GBP2021-12-31
89,577 GBP2020-12-31
Total Inventories
803,929 GBP2021-12-31
626,182 GBP2020-12-31
Debtors
2,815,624 GBP2021-12-31
2,631,197 GBP2020-12-31
Current assets - Investments
1 GBP2020-12-31
Cash at bank and in hand
651,800 GBP2021-12-31
675,633 GBP2020-12-31
Current Assets
4,271,353 GBP2021-12-31
3,933,013 GBP2020-12-31
Creditors
Current
2,419,008 GBP2021-12-31
3,869,921 GBP2020-12-31
Net Current Assets/Liabilities
1,852,345 GBP2021-12-31
63,092 GBP2020-12-31
Total Assets Less Current Liabilities
1,869,144 GBP2021-12-31
152,669 GBP2020-12-31
Creditors
Non-current
989,168 GBP2021-12-31
882,897 GBP2020-12-31
Net Assets/Liabilities
879,976 GBP2021-12-31
-730,228 GBP2020-12-31
Equity
Share premium
3,783,965 GBP2021-12-31
3,321,935 GBP2020-12-31
Retained earnings (accumulated losses)
-2,903,989 GBP2021-12-31
-4,052,163 GBP2020-12-31
Equity
879,976 GBP2021-12-31
-730,228 GBP2020-12-31
Average Number of Employees
42021-01-01 ~ 2021-12-31
42020-01-01 ~ 2020-12-31
Intangible Assets - Gross Cost
650,474 GBP2020-12-31
Intangible Assets - Accumulated Amortisation & Impairment
635,972 GBP2021-12-31
563,184 GBP2020-12-31
Intangible Assets - Increase From Amortisation Charge for Year
72,788 GBP2021-01-01 ~ 2021-12-31
Property, Plant & Equipment - Gross Cost
4,515 GBP2021-12-31
39,326 GBP2020-12-31
Property, Plant & Equipment - Disposals
-36,504 GBP2021-01-01 ~ 2021-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
2,218 GBP2021-12-31
37,039 GBP2020-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,684 GBP2021-01-01 ~ 2021-12-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-36,505 GBP2021-01-01 ~ 2021-12-31
  • STIRLING ANGLIAN PHARMACEUTICALS LIMITED
    Info
    STIRLING ANGLIAN LIMITED - 2013-07-12
    Registered number SC453258
    Hillington Park Innovation Centre Ainslie Road, Hillington Park, Glasgow G52 4RU
    Private Limited Company incorporated on 2013-06-26 (12 years). The company status is Active.
    The last date of confirmation statement was made at 2024-07-06
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.